These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11564672)

  • 1. Up-regulation of p27Kip1 by progestins is involved in the growth suppression of the normal and malignant human endometrial glandular cells.
    Shiozawa T; Horiuchi A; Kato K; Obinata M; Konishi I; Fujii S; Nikaido T
    Endocrinology; 2001 Oct; 142(10):4182-8. PubMed ID: 11564672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone.
    Shiozawa T; Nikaido T; Nakayama K; Lu X; Fujii S
    Mol Hum Reprod; 1998 Sep; 4(9):899-905. PubMed ID: 9783852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse correlation between Skp2 and p27(Kip1) in normal endometrium and endometrial carcinoma.
    Miyamoto T; Horiuchi A; Kashima H; Suzuki A; Yamada T; Kurai M; Konishi I; Shiozawa T
    Gynecol Endocrinol; 2010 Mar; 26(3):220-9. PubMed ID: 19724954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium.
    Lecanda J; Parekh TV; Gama P; Lin K; Liarski V; Uretsky S; Mittal K; Gold LI
    Cancer Res; 2007 Feb; 67(3):1007-18. PubMed ID: 17283133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase Skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium.
    Lahav-Baratz S; Ben-Izhak O; Sabo E; Ben-Eliezer S; Lavie O; Ishai D; Ciechanover A; Dirnfeld M
    Mol Hum Reprod; 2004 Aug; 10(8):567-72. PubMed ID: 15220466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway.
    Ai Z; Wang J; Wang Y; Lu L; Tong J; Teng Y
    Cancer; 2010 Aug; 116(15):3603-13. PubMed ID: 20564127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells.
    Harvat BL; Seth P; Jetten AM
    Oncogene; 1997 May; 14(17):2111-22. PubMed ID: 9160891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S; Chen X; Lu X; Yu Y; Feng Y
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
    Dai D; Kumar NS; Wolf DM; Leslie KK
    Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
    Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
    Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
    Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.
    Waltregny D; Leav I; Signoretti S; Soung P; Lin D; Merk F; Adams JY; Bhattacharya N; Cirenei N; Loda M
    Mol Endocrinol; 2001 May; 15(5):765-82. PubMed ID: 11328857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
    Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogen.
    Ishibashi M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Clin Cancer Res; 2009 Feb; 15(3):804-11. PubMed ID: 19188150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.
    Wang S; Pudney J; Song J; Mor G; Schwartz PE; Zheng W
    Gynecol Oncol; 2003 Feb; 88(2):108-17. PubMed ID: 12586588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2.
    Yang S; Fang Z; Gurates B; Tamura M; Miller J; Ferrer K; Bulun SE
    Mol Endocrinol; 2001 Dec; 15(12):2093-105. PubMed ID: 11731611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
    Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
    Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycodelin blocks progression to S phase and inhibits cell growth: a possible progesterone-induced regulator for endometrial epithelial cell growth.
    Ohta K; Maruyama T; Uchida H; Ono M; Nagashima T; Arase T; Kajitani T; Oda H; Morita M; Yoshimura Y
    Mol Hum Reprod; 2008 Jan; 14(1):17-22. PubMed ID: 18178606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
    Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.